Health Care & Life Sciences » Pharmaceuticals | Taisho Pharmaceutical Holdings Co. Ltd.

Taisho Pharmaceutical Holdings Co. Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
295,969
290,489
289,956
279,750
280,138
261,369
Cost of Goods Sold (COGS) incl. D&A
111,275
112,240
113,143
101,525
97,154
91,206
Gross Income
184,694
178,249
176,813
178,225
182,984
170,163
SG&A Expense
143,009
146,273
147,935
146,260
146,007
138,951
EBIT
41,685
31,976
28,878
31,965
36,977
31,212
Unusual Expense
-
-
851
-
-
17,318
Non Operating Income/Expense
1,866
2,562
2,010
5,458
7,730
43,953
Interest Expense
2
2
2
1
2
2
Pretax Income
51,316
40,162
35,809
41,956
48,070
64,484
Income Tax
17,307
14,103
11,928
11,750
14,701
14,658
Consolidated Net Income
34,009
26,059
23,881
30,205
33,368
49,825
Net Income
32,692
24,528
22,473
28,781
31,679
48,594
Net Income After Extraordinaries
32,692
24,528
22,473
28,781
31,679
48,594
Net Income Available to Common
32,692
24,528
22,473
28,781
31,679
48,593
EPS (Basic)
403.18
302.56
277.75
360.18
396.54
608.80
Basic Shares Outstanding
81
81
81
80
80
80
EPS (Diluted)
403.06
302.41
277.60
359.93
396.21
608.23
Diluted Shares Outstanding
81
81
81
80
80
80
EBITDA
54,072
44,914
41,351
43,635
48,357
42,502
Non-Operating Interest Income
5,296
5,373
5,392
5,134
4,999
4,952
Minority Interest Expense
1,317
1,531
1,408
1,424
1,689
1,231
Equity in Affiliates (Pretax)
2,473
255
382
601
1,634
1,689

About Taisho Pharmaceutical Holdings Co.

View Profile
Address
3-24-1 Takada
Tokyo Tokyo 170
Japan
Employees -
Website http://www.taisho-holdings.co.jp
Updated 07/08/2019
Taisho Pharmaceutical Holdings Co. Ltd. engages in the management and administration of its group companies that manufactures and sells over-the-counter (OTC) drugs, foods, and other goods, etc. It operates through the following segments: Self-Medication and Prescription Pharmaceutical. The Self-Medication segment conducts research and development (R&D), manufacturing and sale of over-the-counter drugs, quasi-drugs, food, and general medical and hygiene supplies.